Evidence map›Paper›PMID 38216941›Full record

ArticleBMC complementary medicine and therapies2024

Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.

Miaoting Yang, Xiaorui Yao, Fan Xia, Shijian Xiang, Waijiao Tang, Benjie Zhou

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Miaoting YangDepartment of Pharmacy, People's Hospital of Longhua, Shenzhen, 518109, Guangdong, China.
Xiaorui YaoDepartment of Pharmacy, Shantou Central Hospital, Shantou, 515041, Guangdong, China.
Fan XiaDepartment of Pharmacy, the Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, PR China.
Shijian XiangDepartment of Pharmacy, the Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, PR China.
Waijiao TangZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Benjie ZhouDepartment of Pharmacy, the Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, PR China. zhoubj23@mail.sysu.edu.cn.
The Seventh Affiliated Hospital of Sun Yat-sen University · CNShantou Central Hospital · CNShenZhen People’s Hospital · CNSun Yat-sen University · CNZhujiang Hospital · CN

Funding

National Natural Science Foundation of China 82003988National Natural Science Foundation of China 82074078Natural Science Foundation of Guangdong Province 2021A1515010567Natural Science Foundation of Guangdong Province 2022A1515010833Shenzhen Key Laboratory of Chinese Medicine Active substance screening and Translational Research ZDSYS20220606100801003the Scientific Research Projects of Medical and Health Institutions of Longhua District, Shenzhen 2023077
6 · The paper itself

Abstract

backgroundEndoplasmic reticulum (ER) stress, promoting lipid metabolism disorders and steatohepatitis, contributes significantly to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Hugan Qingzhi tablets (HQT) has a definite effect in the clinical treatment of NAFLD patients, but its mechanism is still unclear. This study aims to investigate the effects of HQT on ER stress in the liver tissues of NAFLD rats and explore the underlying mechanism.

methodsThe NAFLD rat model was managed with high-fat diet (HFD) for 12weeks. HQT was administrated in a daily basis to the HFD groups. Biochemical markers, pro-inflammatory cytokines, liver histology were assayed to evaluate HQT effects in HFD-induced NAFLD rats. Furthermore, the expression of ER stress-related signal molecules including glucose regulating protein 78 (GRP78), protein kinase RNA-like endoplasmic reticulum kinase (PERK), p-PERK, eukaryotic translation initiation factor 2α (EIF2α), p-EIF2α, activating transcription factor 4 (ATF4), acetyl-coenzyme A-carboxylase (ACC), activating transcription factor (ATF6), and nuclear factor-kappa B-p65 (NF-κB-p65) were detected by western blot and/or qRT-PCR.

resultsThe histopathological characteristics and biochemical data indicated that HQT exhibited protective effects on HFD-induced NAFLD rats. Furthermore, it caused significant reduction in the expression of ERS markers, such as GRP78, PERK, p-PERK, and ATF6, and subsequently downregulated the expression of EIF2α, p-EIF2α ATF4, ACC, and NF-κB-p65.

conclusionsThe results suggested that HQT has protective effect against hepatic steatosis and inflammation in NAFLD rats by attenuating ER stress, and the potential mechanism is through inhibition of PERK and ATF6 pathways.

Indexed as

Drugs, Chinese HerbalNon-alcoholic Fatty Liver DiseaseActivating Transcription Factor 6Activating Transcription FactorsAnimalsEndoplasmic ReticulumEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressHumansNF-kappa BProtein KinasesRatsRNATabletsActivating Transcription Factor 6Activating Transcription FactorsATF6 protein, humanDrugs, Chinese HerbalEndoplasmic Reticulum Chaperone BiPhugan qingzhiNF-kappa BProtein KinasesRNATabletsChinese traditional medicineEndoplasmic reticulum stress (ERS) pathwayHepatoprotective effectHugan Qingzhi tablets (HQT)Non-alcoholic fatty liver disease (NAFLD)

Identifiers

PMID38216941
PMCPMC10785447
OpenAlexW4390823825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.